Navigation Links
Telik Announces First Quarter 2013 Financial Results
Date:5/10/2013

PALO ALTO, Calif., May 10, 2013 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2013.  The net loss for the quarter ended March 31, 2013 was $1.9 million, or $0.46 per share, compared with a net loss of $2.3 million, or $1.25 per share, for the same period in 2012. 

Total research and development expenses (R&D) in the first quarter of 2013 were $0.8 million, compared to $1.0 million for the same period in 2012.  The decrease in R&D expenses was primarily due to lower headcount and related costs, and lower clinical development expenditures as a result of cost reduction efforts.

Total general and administrative expenses (G&A) in the first quarter of 2013 were $1.2 million, compared to $1.3 million for the same period in 2012.  The decrease in G&A expenses was primarily due to lower headcount and related expenses, and lower administrative expenses as a result of cost reduction efforts.

Telik is currently focusing on the clinical development of its lead product candidate, TELINTRA® for Myelodysplastic Syndrome (MDS) and other blood disorders. The design of the company's randomized placebo-controlled Phase 3 registration trial of TELINTRA for the treatment of low to intermediate-1 risk MDS using red-blood-cell transfusion independence as the primary endpoint, in accordance with the FDA's guidance, has been completed.  In order to initiate the registration trial, the company is currently looking to secure funding through the establishment of a corporate partnership, funding from a non-profit agency, or other financing sources. 

As of March 31, 2013, cash, cash equivalents and investments totaled $5.6 million, compared with $5.0 million for the quarter ended December 31, 2012.&#
'/>"/>

SOURCE Telik, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
2. Telik Announces Third Quarter 2012 Financial Results
3. Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
(Date:7/23/2014)... 2014 Research and Markets   ... Electrophysiology Ablation Catheters Market 2014-2018" report to ... Catheter ablation is a minimally ... electrical pathways from sections of the heart that ... arrhythmias). Cardiac arrhythmias can be of several types, ...
(Date:7/23/2014)... -- Creekridge Capital, an independent vendor-focused finance company, ... far in 2014 to their portfolio of contractual ... both the healthcare and technology industries. They range ... companies. Each of these new vendors take advantage ... standard leasing products, subscription solutions, a dedicated revolving ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Creekridge Capital Signs Several New Vendor Partners 2
... Sigma-Aldrich (Nasdaq: SIAL ) announced today that it ... leader in bench top flow chemistry instruments, the terms ... of approximately 400 CatCart® catalyst products for flow chemistry ... and CatCart catalyst cartridges provide organic chemists in academic ...
... Accumetrics, Inc., developer and marketer of the VerifyNow® ... measuring an individual,s response to multiple antiplatelet agents, announced ... that will raise $16.5 million in new capital. ... into 2011, came from the company,s existing investors, including ...
Cached Medicine Technology:Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market 2Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market 3Accumetrics Announces $16.5M in New Capital Financing 2Accumetrics Announces $16.5M in New Capital Financing 3
(Date:7/23/2014)... AidJoy is delighted to announce that it ... on September 5, 2014 from 7:00 to 11:00 p.m. ... expected to attend this semi-formal event. , "We are elated ... six years," says Jess Dennis, Director of Operations and organizer ... this moment in AidJoy’s history before we launch into our ...
(Date:7/23/2014)... The European Bio fertilizers Market Report ... with analysis and forecast of revenue. The bio fertilizers ... $ 2,566.4 million in 2012 to $4,582.2 million by ... 2017. , Browse through the TOC of the European ... the in-depth analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html ...
(Date:7/23/2014)... "I wanted a better way to keep track of all ... pressure and pulse rate," said an inventor from Long Beach, ... a bunch of different devices, so I invented one that ... to make it easier to monitor health conditions. The invention ... enables the user to have more control over his or ...
(Date:7/23/2014)... 2014) Statins, a class of drugs commonly used ... of developing Barrett,s esophagus, according to a new study ... official journal of the American Gastroenterological Association. Obese patients ... use. , "Patients who received statins had a 43 ... compared to non-users," said study author Hashem B. El-Serag, ...
(Date:7/23/2014)... some high-profile athletes who suffered repeated blows to the ... their brains. Those clumps suggest the athletes had a ... working on tests that might be able to detect ... in Chemical & Engineering News (C&EN) , the ... In the article, Lauren Wolf, a senior editor at ...
Breaking Medicine News(10 mins):Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2
... Oct. 15 (HealthDay News) -- Women in their 40s who are ... for having mammograms to 50 may find clarity in a new ... save lives. "The bottom line is everyone over the age ... chief of breast imaging at Lenox Hill Hospital in New York ...
... higher intake of alcohol during pregnancy adversely affects the ... other problems in the child. However, most recent ... light drinking by the mother during pregnancy. The ... factors of the mother may have large effects on ...
... prodigious precursors of all the tissues in our body, ... unfortunately, cancer. Now research from Rockefeller University shows that ... live for too long, can increase the odds of ... cell death in precursor cells for blood, or hematopoietic ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Oct. 14 ... may help alleviate the symptoms of fibromyalgia, a small study ... syndrome, were enrolled in a two-hour yoga class that met ... women diagnosed with the condition were put on a waiting ...
... Gardner HealthDay Reporter , THURSDAY, Oct. 14 ... of lovelorn Stanford undergrads, researchers discovered that high-octane romantic ... effect isn,t just that the person is distracted by ... too. Instead, the researchers found that feeling "head-over-heels" activates ...
... is available in Spanish . Researchers a ... Nuclear Medicine, Hospital Virgen de las Nieves at Granada found ... of a structural analog of glucose labeled with a positron-emitting ... relatively rare disease with high mortality rates among most patients ...
Cached Medicine News:Health News:Latest Findings Back Mammograms for Women in Their 40s 2Health News:Latest Findings Back Mammograms for Women in Their 40s 3Health News:2 studies present new data on effects of alcohol during pregnancy 2Health News:Gene identified that prevents stem cells from turning cancerous 2Health News:Gene identified that prevents stem cells from turning cancerous 3Health News:Yoga May Combat Fibromyalgia Symptoms 2Health News:Yoga May Combat Fibromyalgia Symptoms 3Health News:Yoga May Combat Fibromyalgia Symptoms 4Health News:Romantic Love: Nature's Painkiller? 2Health News:Romantic Love: Nature's Painkiller? 3Health News:New method is found for accurate diagnosis of gall bladder cancer, 1 of the most deadly 2
Surgical Stainless Steel Adult 16.5....
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Medicine Products: